Company Information for INHIBITAXIN LIMITED
Montague Place Quayside, Chatham Maritime, Chatham, KENT, ME4 4QU,
|
Company Registration Number
08582765
Private Limited Company
Liquidation |
Company Name | |
---|---|
INHIBITAXIN LIMITED | |
Legal Registered Office | |
Montague Place Quayside Chatham Maritime Chatham KENT ME4 4QU Other companies in CT13 | |
Company Number | 08582765 | |
---|---|---|
Company ID Number | 08582765 | |
Date formed | 2013-06-25 | |
Country | ||
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Liquidation | |
Lastest accounts | 2019-06-30 | |
Account next due | 30/06/2021 | |
Latest return | 25/06/2016 | |
Return next due | 23/07/2017 | |
Type of accounts | SMALL |
Last Datalog update: | 2023-12-12 13:03:26 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Officer | Role | Date Appointed |
---|---|---|
DAVID JOHN GRAINGER |
||
KEVIN STUART JOHNSON |
||
SIMON LEMPRIERE WESTBROOK |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
BIRD & BIRD COMPANY SECRETARIES LIMITED |
Company Secretary | ||
THE CAMBRIDGE PARTNERSHIP LIMITED |
Company Secretary |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
CRITICAL PRESSURE LIMITED | Director | 2017-10-02 | CURRENT | 2017-06-20 | Active | |
DC EUROPA LIMITED | Director | 2017-06-20 | CURRENT | 2017-06-20 | Liquidation | |
THE FOUNDRY (CAMBRIDGE) LIMITED | Director | 2017-06-16 | CURRENT | 2017-06-16 | Active | |
REBALANCE (CAMBRIDGE) LIMITED | Director | 2016-12-06 | CURRENT | 2016-12-06 | Liquidation | |
CORRECTA4 BIO LIMITED | Director | 2016-04-19 | CURRENT | 2016-04-19 | Liquidation | |
HUMAN ANTIBODY FACTORY LIMITED | Director | 2015-10-06 | CURRENT | 2015-10-06 | Liquidation | |
ABC MEDICINES LIMITED | Director | 2015-09-15 | CURRENT | 2015-09-15 | Active - Proposal to Strike off | |
CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED | Director | 2015-07-15 | CURRENT | 2015-07-15 | Active | |
TOTAL DIAGNOSTICS LIMITED | Director | 2015-03-24 | CURRENT | 2015-03-24 | Dissolved 2018-07-10 | |
THE CAMBRIDGE PARTNERSHIP LIMITED | Director | 2014-11-01 | CURRENT | 2012-11-09 | Active | |
Z FACTOR LIMITED | Director | 2014-10-21 | CURRENT | 2014-10-21 | Active | |
METHUSELAH HEALTH UK LIMITED | Director | 2014-09-09 | CURRENT | 2014-09-09 | Active | |
FUNXIONAL THERAPEUTICS LIMITED | Director | 2014-09-01 | CURRENT | 2005-08-11 | Dissolved 2017-12-12 | |
PURPLE PHARMACEUTICALS LIMITED | Director | 2013-07-12 | CURRENT | 2013-07-12 | Dissolved 2017-09-19 | |
ONCOMET LIMITED | Director | 2013-02-28 | CURRENT | 2013-02-28 | Dissolved 2015-12-23 | |
RXCELERATE LIMITED | Director | 2012-11-07 | CURRENT | 2012-11-07 | Active | |
METHUSELAH HEALTH UK LIMITED | Director | 2018-04-06 | CURRENT | 2014-09-09 | Active | |
ULTRAHUMAN ONE LIMITED | Director | 2017-04-06 | CURRENT | 2017-02-28 | Liquidation | |
ULTRAHUMAN THIRTEEN LIMITED | Director | 2017-04-06 | CURRENT | 2017-03-03 | Liquidation | |
LOCKBODY THERAPEUTICS LTD | Director | 2017-04-06 | CURRENT | 2017-03-03 | Active | |
ULTRAHUMAN TWELVE LIMITED | Director | 2017-04-06 | CURRENT | 2017-03-03 | Liquidation | |
ULTRAHUMAN SEVEN LIMITED | Director | 2017-04-06 | CURRENT | 2017-03-03 | Liquidation | |
GRANULAR THERAPEUTICS LIMITED | Director | 2017-04-06 | CURRENT | 2017-03-03 | Active | |
ULTRAHUMAN TEN LIMITED | Director | 2017-04-06 | CURRENT | 2017-03-03 | Liquidation | |
ULTRAHUMAN ELEVEN LIMITED | Director | 2017-04-06 | CURRENT | 2017-03-03 | Liquidation | |
ULTRAHUMAN FOURTEEN LIMITED | Director | 2017-04-06 | CURRENT | 2017-03-03 | Liquidation | |
ULTRAHUMAN TWO LIMITED | Director | 2017-04-06 | CURRENT | 2017-03-01 | Active - Proposal to Strike off | |
ULTRAHUMAN THREE LIMITED | Director | 2017-04-06 | CURRENT | 2017-03-03 | Liquidation | |
ULTRAHUMAN FOUR LIMITED | Director | 2017-04-06 | CURRENT | 2017-03-03 | Active - Proposal to Strike off | |
ULTRAHUMAN NINE LIMITED | Director | 2017-04-06 | CURRENT | 2017-03-03 | Liquidation | |
ULTRAHUMAN EIGHT LIMITED | Director | 2017-04-06 | CURRENT | 2017-03-03 | Active | |
REBALANCE (CAMBRIDGE) LIMITED | Director | 2016-12-06 | CURRENT | 2016-12-06 | Liquidation | |
SUPERX LIMITED | Director | 2016-01-07 | CURRENT | 2015-11-10 | Liquidation | |
ULTRAHUMAN LIMITED | Director | 2015-12-16 | CURRENT | 2015-11-24 | Liquidation | |
CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED | Director | 2015-10-30 | CURRENT | 2015-07-15 | Active | |
CRESCENDO BIOLOGICS LIMITED | Director | 2015-07-07 | CURRENT | 2007-11-13 | Active | |
CAPELLA BIOSCIENCE LTD | Director | 2014-12-19 | CURRENT | 2014-11-07 | Active | |
APCINTEX LIMITED | Director | 2014-06-16 | CURRENT | 2014-06-16 | Active | |
LETSBEATSEPSIS | Director | 2014-05-19 | CURRENT | 2014-05-19 | Active - Proposal to Strike off | |
B3NGF LTD | Director | 2013-02-14 | CURRENT | 2013-02-14 | Dissolved 2015-12-21 | |
LEVICEPT LTD | Director | 2012-08-23 | CURRENT | 2012-08-23 | Active | |
LEVICEPT LTD | Director | 2012-08-23 | CURRENT | 2012-08-23 | Active |
Resolution | 2021-07-20 |
Notices to | 2021-07-20 |
Appointmen | 2021-07-20 |
Total # Mortgages/Charges | 0 |
---|---|
Mortgages/Charges outstanding | 0 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 0 |
Average | Max |
This shows the max and average number of mortgages for companies with the same SIC code of 72110 - Research and experimental development on biotechnology
|
|
|
These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on INHIBITAXIN LIMITED
The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as INHIBITAXIN LIMITED are:
Initiating party | Event Type | Resolution | |
---|---|---|---|
Defending party | INHIBITAXIN LIMITED | Event Date | 2021-07-20 |
Initiating party | Event Type | Notices to | |
Defending party | INHIBITAXIN LIMITED | Event Date | 2021-07-20 |
Initiating party | Event Type | Appointmen | |
Defending party | INHIBITAXIN LIMITED | Event Date | 2021-07-20 |
Name of Company: INHIBITAXIN LIMITED Company Number: 08582765 Nature of Business: Research and experimental development on biotechnology Registered office: Office 20, Second Floor Innovation House, Ra… | |||
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |